CASP3 and lung carcinoma: Protein level analysis via Western blotting shows that in lung cancer cells treated with cisplatin or CRAd, the level of anti-apoptotic bcl-2 was reduced while pro-apoptotic bax and caspase-3 levels were enhanced (Figure 6c).